Meningitis antigens

Meningitis antigens represent a diverse set of molecular structures found on the surface of pathogens responsible for meningitis, a life-threatening inflammation of the brain and spinal cord membranes. The most prominent targets include the capsular polysaccharides of Neisseria meningitidis (serogroups A, B, C, W, and Y), Streptococcus pneumoniae, and Haemophilus influenzae type b, as well as specific outer membrane proteins like Factor H binding protein (fHbp) and Porin A [1, 5, 13]. These antigens play a dual role: they are critical virulence factors that allow bacteria to survive in the bloodstream and cross the blood-brain barrier, and they are the primary targets for the host's immune system [5]. Therapeutically, meningitis antigens are the active components in vaccines designed to stimulate long-term immunity. Conjugate vaccines, which link polysaccharides to carrier proteins, are particularly effective in inducing a T-cell dependent immune response in infants and young children [6, 13]. Beyond prevention, these antigens serve as essential biomarkers in diagnostic medicine; their presence in cerebrospinal fluid can be rapidly detected to confirm a diagnosis and guide antibiotic therapy [5, 15]. Despite the success of current vaccines, challenges remain, such as the high degree of antigenic variation in serogroup B N. meningitidis, which necessitated the development of protein-based rather than polysaccharide-based vaccines [5].

Other names

Meningococcal antigensPneumococcal antigensHaemophilus influenzae type b antigensCapsular polysaccharidesBacterial meningitis antigens

Induction of active immunity through the production of pathogen-specific antibodies (e.g., bactericidal antibodies) and the establishment of immunological memory [5, 13].